Ambrose Kristen — SEC insider filings
SEC reporting owner CIK 1856587. 24 insider filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2022-02-03 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 13 filings — 11,402 shares, $4,926,492 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 1,557 shares @ $489.46 ($762,089) in VERTEX PHARMACEUTICALS INC / MA, filed 2026-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | SVP & Chief Accounting Officer | 24 | — | 19 legs · 11,402 sh · $4,926,492 | 26 |
Insider filings — Ambrose Kristen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 5,000 @ $0 | EDGAR |
| 2026-03-02 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 357 @ $483.36 | EDGAR |
| 2026-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 546 @ $485.11 · Sale (S): 223 @ $486.35 | EDGAR |
| 2026-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 1,809 @ $0 · Tax withholding (F): 598 @ $483.75 · Sale (S): 1,557 @ $489.46 · Sale (S): 638 @ $473.68 | EDGAR |
| 2026-02-18 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,393 @ $487.76 | EDGAR |
| 2026-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 592 @ $468.41 · Sale (S): 1,376 @ $460.43 | EDGAR |
| 2026-01-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,950 @ $0 · Grant/award (A): 1,300 @ $0 | EDGAR |
| 2025-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 1,241 @ $479.61 | EDGAR |
| 2025-02-26 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 828 @ $483.28 · Sale (S): 884 @ $480.95 | EDGAR |
| 2025-02-19 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 564 @ $463.46 · Sale (S): 671 @ $455.06 | EDGAR |
| 2025-02-14 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,080 @ $0 | EDGAR |
| 2025-02-12 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 591 @ $467.98 · Sale (S): 1,376 @ $459.83 | EDGAR |
| 2025-02-06 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,566 @ $0 · Grant/award (A): 1,854 @ $0 | EDGAR |
| 2024-04-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 225 @ $418.10 · Sale (S): 240 @ $419 | EDGAR |
| 2024-02-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 828 @ $431.79 · Sale (S): 883 @ $425.70 | EDGAR |
| 2024-02-13 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 591 @ $422.74 · Sale (S): 1,374 @ $420.24 | EDGAR |
| 2024-02-08 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,950 @ $0 · Grant/award (A): 1,853 @ $0 | EDGAR |
| 2023-06-01 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 289 @ $329.82 | EDGAR |
| 2023-04-04 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 176 @ $313.74 | EDGAR |
| 2023-02-28 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 502 @ $289.12 · Sale (S): 982 @ $287.25 · Sale (S): 183 @ $288.68 · Sale (S): 42 @ $289.63 | EDGAR |
| 2023-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,566 @ $0 · Grant/award (A): 2,950 @ $0 | EDGAR |
| 2022-04-27 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale (S): 60 @ $267.37 · Sale (S): 80 @ $268.46 · Sale (S): 83 @ $269.51 · Sale (S): 104 @ $271.68 | EDGAR |
| 2022-04-05 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax withholding (F): 137 @ $263.09 | EDGAR |
| 2022-02-03 | 4 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/award (A): 2,566 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-01-31 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856587 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs